Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer
Clinical trial NCT00146562 · COMPLETED
Trial details
- NCT number
- NCT00146562
- Sponsor
- Harold J. Burstein, MD, PhD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Primary completion
- 2007-05-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.